Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: Case report and review of the literature and medwatch database

Pharmacotherapy

Volumn 28, Issue 4, 2008, Pages 540-548

  Knudsen, James F ^a   Sokol, Gerald H ^a,b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Bleeding; Chondroitin sulfate; Glucosamine; INR; International normalized ratio; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMLODIPINE BESYLATE; ASCORBIC ACID; CHONDROITIN SULFATE; EZETIMIBE; FISH OIL; GLUCOSAMINE; HYDROCHLOROTHIAZIDE; LISINOPRIL; SIMVASTATIN; WARFARIN;

AGED; ANAMNESIS; ARTHRITIS; ARTICLE; CASE REPORT; DIETARY INTAKE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MALE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CHONDROITIN SULFATES; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; DRUG INTERACTIONS; FEMALE; GLUCOSAMINE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; WARFARIN;

EID: 41549157783     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.4.540     Document Type: Article

References (21)

1. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complimentary and alternative medicine use among adults: United States 2002. National Center for Health Statistics; 2004 Advance Data from Vial and Health Statistics, No. 343.
2. Villacis J, Rice TR, Bucci LR, et al. Do shrimp-allergic individuals tolerate shrimp-derived glucosamine? Clin Exp Allergy 2006;36:1457-61.
3. Wysowski DK, Nourhjah P, Swartz L. Bleeding complications with warfarin use a prevalent adverse effect resulting in regulatory action. Arch Intern Med 2007;167:1414-19.
4. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25.
5. Gage BF, Milligan PE. Pharmacology and pharmacokinetics of warfarin and other coumarins when used with supplements. Thromb Res 2005;117:55-9.
6. Rozenfeld V, Crain JL, Callahan AK. Possible augmentation of warfarin effect by glucosamine-chondroitin. Am J Health-Syst Pharm 2004;61:306-7.
7. Yue QY, Strandell J, Myrberg O. Concomitant use of glucosamine may potentiate the effect of warfarin. The Uppsala monitoring centre. Available from www.who-umc.org. Accessed June 23, 2007.
8. General Accounting Office. Adverse drug event: magnitude of health risk is uncertain because of limited incidence data. Publication no. GAO/HEHS-00-21. Washington, DC: General Accounting Office; 2000.
9. Couris R, Tataronis G, McCloskey W, et al. Dietary vitamin K variability affects INR coagulation indicies. Int J Vitam Nutr Res 2006;76:65-74.
10. Shearer MJ, Bach A, Kohlmeier M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr 1996;124:S1181-6.
11. Berkner K. The vitamin K-dependent carboxylase: glucosamine-induced endoplasmic dysfunction has been reported in various animal models. Ann Rev Nutr 2005;25:127-49.
12. Werstuck GH, Khan MI, Femia G, et al. Glucosamine-induced endoplasmic reticulum dysfunction within the hepatocyte is associated with accelerated atherosclerosis in a hyperglycemic mouse model. Diabetes 2006;55:93-101.
13. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108:231-46.
14. Rieder MJ, Reiner AP, Rettie AE. γ-Glutamyl carboxylase tagSNPs have limited utility for predicting warfarin maintenance dose. J Thromb Haemost 2007;5:2227-34.
15. Ouirke W, Cahill M, Perera K, Sargent J, Conway J. Warfarin prevalence, indications for use and haemorrhagic events. Ir Med J 2007;100:402-4.
16. Bristol-Myers Squibb Company. Coumadin (warfarin sodium) package insert. Princeton, NJ; 2003.
17. Goldstein A, Aronow L, Kalman SM, eds. The absorption, distribution and elimination of drugs. In: Principles of drug action: the basis of pharmacology, 2nd ed. New York: John Wiley & Sons, 1973:160.
18. Setnikar I, Palumbo R, Canali S. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993;43:1109-13.
19. Suttie JW, Muhah-Schendel LL, Shah DV, et al. Vitamin K deficiency from dietary vitamin K restriction in humans. Am J Clin Nutr 1988;47:475-80.
20. Bechtold H, Andrassy K, Jahnchen E. Evidence for impaired hepatic vitamin K metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost 1984;51:358-61.
21. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007;109:2419-23.